Devonian Health Group Inc
XTSX:GSD
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
National Fuel Gas Co
NYSE:NFG
|
US |
Devonian Health Group Inc
Change in Working Capital
Devonian Health Group Inc
Change in Working Capital Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Change in Working Capital | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Devonian Health Group Inc
XTSX:GSD
|
Change in Working Capital
-CA$5m
|
CAGR 3-Years
-141%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Bausch Health Companies Inc
TSX:BHC
|
Change in Working Capital
-$219m
|
CAGR 3-Years
18%
|
CAGR 5-Years
10%
|
CAGR 10-Years
11%
|
|
|
Canopy Growth Corp
TSX:WEED
|
Change in Working Capital
CA$12.9m
|
CAGR 3-Years
-52%
|
CAGR 5-Years
-48%
|
CAGR 10-Years
-1%
|
|
|
Cronos Group Inc
TSX:CRON
|
Change in Working Capital
-$34.4m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
0%
|
CAGR 10-Years
N/A
|
|
|
Mind Medicine (MindMed) Inc
NASDAQ:MNMD
|
Change in Working Capital
$13.6m
|
CAGR 3-Years
59%
|
CAGR 5-Years
50%
|
CAGR 10-Years
N/A
|
|
|
K
|
Knight Therapeutics Inc
TSX:GUD
|
Change in Working Capital
CA$1.9m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Devonian Health Group Inc
Glance View
Devonian Health Group, Inc. is a pharmaceutical company, which engages in the development of botanical drugs. The company is headquartered in Pointe-Claire, Quebec. The company went IPO on 2014-09-09. The Company’s flagship product, Thykamine, the pharmaceutical product issued from its SUPREX platform, is a product for the prevention and treatment of health conditions related to inflammation and oxidative stress. The anti-inflammatory, anti-oxidative and immunomodulatory properties of Thykamine have been demonstrated by a considerable number of in vitro and in vivo studies, as well as in a Phase IIa clinical study in patients with Mild-to-Moderate distal Ulcerative Colitis and in a Phase II clinical trial in adult patients with Mild-to-Moderate Atopic Dermatitis. The firm is also involved in the development of cosmeceutical products.
See Also
What is Devonian Health Group Inc's Change in Working Capital?
Change in Working Capital
-5m
CAD
Based on the financial report for Oct 31, 2025, Devonian Health Group Inc's Change in Working Capital amounts to -5m CAD.
What is Devonian Health Group Inc's Change in Working Capital growth rate?
Change in Working Capital CAGR 3Y
-141%
The average annual Change in Working Capital growth rates for Devonian Health Group Inc have been -141% over the past three years .
